| __timestamp | Johnson & Johnson | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 293000 |
| Thursday, January 1, 2015 | 9046000000 | 1002000 |
| Friday, January 1, 2016 | 9095000000 | 888000 |
| Sunday, January 1, 2017 | 10554000000 | 19623000 |
| Monday, January 1, 2018 | 10775000000 | 30421000 |
| Tuesday, January 1, 2019 | 11355000000 | 34794000 |
| Wednesday, January 1, 2020 | 12340000000 | 28304000 |
| Friday, January 1, 2021 | 14277000000 | 56886000 |
| Saturday, January 1, 2022 | 14135000000 | 100894000 |
| Sunday, January 1, 2023 | 15048000000 | 159765000 |
| Monday, January 1, 2024 | 17232000000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceutical innovation, research and development (R&D) investments are pivotal. Over the past decade, Johnson & Johnson has consistently demonstrated its commitment to innovation, with R&D expenses growing by approximately 77% from 2014 to 2023. In 2023 alone, the company invested around $15 billion, underscoring its role as a leader in healthcare advancements.
Conversely, Viridian Therapeutics, Inc., a smaller player in the industry, has shown remarkable growth in its R&D spending. From a modest $293,000 in 2014, Viridian's investment surged to nearly $160 million by 2023, marking an exponential increase of over 54,000%. This growth reflects Viridian's aggressive pursuit of novel therapies and its potential to disrupt the market.
This comparison highlights the diverse strategies of established giants and emerging innovators in shaping the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Cost of Revenue Trends: Johnson & Johnson vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: MannKind Corporation and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.